Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient

NCT00795093 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00795093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
January 31, 2010
Enrollment
552 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease (gerd)